Step by Stepa HemeOncBuddy patient portal

THP

Illustration: THP

Say it: tee-aitch-PEE

Docetaxel, trastuzumab and pertuzumab

THP is a chemotherapy medicine plus two HER2 targeted antibodies, and it is the usual first treatment for HER2 positive breast cancer that has spread.

Also called: THP chemo, docetaxel Herceptin Perjeta, HP plus docetaxel, pertuzumab trastuzumab docetaxel, THP with Phesgo, paclitaxel HP

What it is

HER2 is a protein that drives some breast cancers to grow. Trastuzumab and pertuzumab block HER2 in two different ways, and docetaxel kills dividing cancer cells. For cancer that has spread, the goal is to shrink it and keep it under control for as long as possible. After the chemotherapy part ends, the antibodies usually continue on their own.

TTaxotere (docetaxel)
HHerceptin (trastuzumab)
PPerjeta (pertuzumab)

Often used for

Paclitaxel in place of docetaxel
Some people get weekly paclitaxel instead of docetaxel, which can cause less fluid buildup and fewer low blood counts.
HP maintenance
After chemotherapy stops, trastuzumab and pertuzumab continue every 3 weeks for as long as they keep working. People with hormone receptor positive cancer often add hormone pills.
With Phesgo (shot form)
Trastuzumab and pertuzumab can be given together as one shot under the skin, which takes minutes instead of hours.

The medicines in this plan

Docetaxel
Taxane chemotherapy. Given through a vein over about 1 hour on day 1, usually for about 6 cycles.
Trastuzumab
Antibody that blocks HER2. Given through a vein or as a shot on day 1 of each cycle; the first dose takes longer.
Pertuzumab
Antibody that blocks HER2 in a different spot than trastuzumab. Given through a vein on day 1 of each cycle.

How you get it

THP is given in an outpatient infusion clinic every 21 days. The first visit can take 4 to 5 hours, and later ones are shorter. Docetaxel is usually given for about 6 cycles (about 4 months), then the two antibodies continue alone every 3 weeks as long as they help. Your schedule may be different.

A typical cycle

Day before
Start dexamethasone pills, as prescribed, to prevent reactions and fluid buildup from docetaxel.
Day 1
Blood tests, then pertuzumab, trastuzumab and docetaxel through a vein, with time to watch for reactions.
Days 2 to 10
Diarrhea, tiredness and body aches are most likely. Blood counts are lowest around days 7 to 10.
Days 11 to 21
Recovery. Visit and blood tests before the next cycle.
After chemotherapy
Trastuzumab and pertuzumab every 3 weeks, with scans every few months.

Common side effects and what helps

Call your care team right away if you have

Good to know

At home

Questions to ask

Breast cancer

Sources

Quick answers

What is THP?
THP is a chemotherapy medicine plus two HER2 targeted antibodies, and it is the usual first treatment for HER2 positive breast cancer that has spread. Docetaxel, trastuzumab and pertuzumab.
What does THP stand for?
T = Taxotere (docetaxel); H = Herceptin (trastuzumab); P = Perjeta (pertuzumab).
How is THP given?
THP is given in an outpatient infusion clinic every 21 days. The first visit can take 4 to 5 hours, and later ones are shorter. Docetaxel is usually given for about 6 cycles (about 4 months), then the two antibodies continue alone every 3 weeks as long as they help. Your schedule may be different.
What are the common side effects of THP?
Diarrhea, very common with pertuzumab. Hair loss during docetaxel. Tiredness. Low white blood cell counts. Rash, dry skin and nail changes. Tingling or numbness in fingers and toes. Swelling of the legs from fluid. Mouth sores and taste changes.
When should I call my care team during THP?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; Diarrhea 4 or more times a day above normal, or with dizziness; Shortness of breath, swelling of the legs, or a racing heartbeat; Chills, rash, wheezing or face swelling during or after an infusion; Vomiting or you cannot keep fluids down; New cough or trouble breathing.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.